Vandortuzumab
Vandortuzumab is a CHO-expressed humanized antibody targeting STEAP1. Vandortuzumab has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 145.5 kDa. The isotype control for Vandortuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001) .
Product Specifications
Product Name Alternative
DSTP-3086S Antibody; RG-7450 Antibody
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/vandortuzumab.html
Purity
99.00
Molecular Weight
(145.5 kDa)
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
134866-ML750 100 µL
Dual Specificity Protein Kinase TTK (TTK, MPS1, MPS1L1, Phosphotyrosine Picked Threonine-protein Kinase, PYT) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
RC225679L4V 200 µL
ALS2CR12 (FLACC1) (NM_001127391) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
316375-01 50 µg
FoxO4 (FOXO4, AFX, AFX1, MLLT7, Forkhead Box Protein O4, Fork Head Domain Transcription Factor AFX1)
Sign In for Pricing
View Details 
316375-02 100 µg
FoxO4 (FOXO4, AFX, AFX1, MLLT7, Forkhead Box Protein O4, Fork Head Domain Transcription Factor AFX1)
Sign In for Pricing
View Details MBS9422358-01 0.02 mg
Recombinant Human Potassium voltage-gated channel subfamily D member 2
Sign In for Pricing
View Details